Case Reports
doi: 10.1089/cap.2004.14.443.
Atomoxetine for the treatment of pediatric nocturnal enuresis
Affiliations
- PMID: 15650501
- DOI: 10.1089/cap.2004.14.443
Item in Clipboard
Case Reports
Atomoxetine for the treatment of pediatric nocturnal enuresis
J Child Adolesc Psychopharmacol.
2004 Fall.
Abstract
Current treatments for pediatric nocturnal enuresis rely upon the use of behavioral interventions, such as enuresis alarms, and pharmacological interventions, such as antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics. However, a considerable number of patients do not respond fully to any of these interventions, in spite of optimal behavioral management and medication dosing. This report describes 4 children with attention deficit hyperactivity disorder (ADHD) comorbid with nocturnal enuresis. Each child was treated with atomoxetine for ADHD and experienced serendipitous resolution of enuresis.
Similar articles
-
Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis.J Child Adolesc Psychopharmacol. 2006 Dec;16(6):699-711. doi: 10.1089/cap.2006.16.699. J Child Adolesc Psychopharmacol. 2006. PMID: 17201614 Clinical Trial.
-
Atomoxetine ameliorates nocturnal enuresis with subclinical attention-deficit/hyperactivity disorder.Pediatr Int. 2017 Feb;59(2):181-184. doi: 10.1111/ped.13111. Epub 2016 Oct 19. Pediatr Int. 2017. PMID: 27501068
-
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders.J Child Adolesc Psychopharmacol. 2005 Dec;15(6):996-1004. doi: 10.1089/cap.2005.15.996. J Child Adolesc Psychopharmacol. 2005. PMID: 16379520
-
New options in the pharmacological management of attention-deficit/hyperactivity disorder.Am J Manag Care. 2004 Jul;10(4 Suppl):S117-24. Am J Manag Care. 2004. PMID: 15352538 Review.
-
Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder.Arch Dis Child. 2005 Feb;90 Suppl 1(Suppl 1):i26-9. doi: 10.1136/adc.2004.059386. Arch Dis Child. 2005. PMID: 15665154 Free PMC article. Review.
Cited by
-
Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence.Paediatr Drugs. 2008;10(1):39-47. doi: 10.2165/00148581-200810010-00005. Paediatr Drugs. 2008. PMID: 18162007 Review.
-
Comorbidity of ADHD and incontinence in children.Eur Child Adolesc Psychiatry. 2015 Feb;24(2):127-40. doi: 10.1007/s00787-014-0577-0. Epub 2014 Jul 1. Eur Child Adolesc Psychiatry. 2015. PMID: 24980793 Review.
-
Optimising the management of children with concomitant bladder dysfunction and behavioural disorders.Eur Child Adolesc Psychiatry. 2023 Oct;32(10):1989-1999. doi: 10.1007/s00787-022-02016-4. Epub 2022 Jun 29. Eur Child Adolesc Psychiatry. 2023. PMID: 35767104 Free PMC article. Review.
-
Management of nocturnal enuresis - myths and facts.World J Nephrol. 2016 Jul 6;5(4):328-38. doi: 10.5527/wjn.v5.i4.328. World J Nephrol. 2016. PMID: 27458562 Free PMC article. Review.
-
Commentary: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series.J Can Acad Child Adolesc Psychiatry. 2011 Feb;20(1):56. J Can Acad Child Adolesc Psychiatry. 2011. PMID: 21286369 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
